FSA chairman Callum McCarthy's diatribe, against European legislation affecting the way financial products may be marketed across borders, hits the pages of most newspapers.
The Markets in Financial Instruments Directive (MiFID) has not undergone a sufficient cost-benefit analysis, McCarthy says, which means it is not possible to tell whether anyone will benefit from its introduction. The Times quotes an implementation cost of up to £1bn in the UK alone, as, for example, City firms are forced to invest in additional IT infrastructure to meet the rules. The Scotsman calls McCarthy’s comments “a broadside” against Brussels, which is not at all in the common diplomatic style of regulatory discussions. However, it also says the comments are “noteworthy”. Tha...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes